IGFBP-3, hypoxia and TNF-α inhibit adiponectin transcription

Biochemical and Biophysical Research Communications

Volumn 382, Issue 4, 2009, Pages 785-789

  Zappalà, Giovanna ^a   Rechler, Matthew M ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Adiponectin; Hypoxia; Insulin like growth factor binding protein 3 (IGFBP 3); Retinoid X receptor (RXR ); Tumor necrosis factor (TNF )

Indexed keywords

ADIPONECTIN; COBALT CHLORIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; RETINOID X RECEPTOR ALPHA; ROSIGLITAZONE; SOMATOMEDIN BINDING PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; FIBROBLAST; HYPOXIA; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

3T3-L1 CELLS; ADIPONECTIN; ANIMALS; CELL HYPOXIA; COBALT; FIBROBLASTS; GENES, REPORTER; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MICE; OBESITY; PPAR GAMMA; RETINOID X RECEPTOR ALPHA; THIAZOLIDINEDIONES; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 64549164501     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.112     Document Type: Article

References (38)

1. Bouskila M., Pajvani U.B., and Scherer P.E. Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?. Int. J. Obes. (Lond.) 29 Suppl. 1 (2005) S17-S23
2. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., and Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116 (2006) 1784-1792
3. Guerre-Millo M. Adiponectin: an update. Diabetes Metab. 34 (2008) 12-18
4. Cornier M.A., Dabelea D., Hernandez T.L., Lindstrom R.C., Steig A.J., Stob N.R., Van Pelt R.E., Wang H., and Eckel R.H. The metabolic syndrome. Endocr. Rev. (2008)
5. Gallagher E.J., LeRoith D., and Karnieli E. The metabolic syndrome-from insulin resistance to obesity and diabetes. Endocrinol. Metab. Clin. North Am. 37 (2008) 559-579 vii
6. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr. Rev. 26 (2005) 439-451
7. Oh D.K., Ciaraldi T., and Henry R.R. Adiponectin in health and disease. Diabetes Obes. Metab. 9 (2007) 282-289
8. Yki-Jarvinen H. Thiazolidinediones. N. Engl. J. Med. 351 (2004) 1106-1118
9. Shulman A.I., and Mangelsdorf D.J. Retinoid X receptor heterodimers in the metabolic syndrome. N. Engl. J. Med. 353 (2005) 604-615
10. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., Nagaretani H., Matsuda M., Komuro R., Ouchi N., Kuriyama H., Hotta K., Nakamura T., Shimomura I., and Matsuzawa Y. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50 (2001) 2094-2099
11. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., and Shimomura I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52 (2003) 1655-1663
12. Rosen E.D., and Spiegelman B.M. PPARgamma: a nuclear regulator of metabolism, Differentiation, and cell growth. J. Biol. Chem. 276 (2001) 37731-37734
13. Kim H.S., Ali O., Shim M., Lee K.W., Vuguin P., Muzumdar R., Barzilai N., and Cohen P. Insulin-like growth factor binding protein-3 induces insulin resistance in adipocytes in vitro and in rats in vivo. Pediatr. Res. 61 (2007) 159-164
14. Liu B., Lee H.Y., Weinzimer S.A., Powell D.R., Clifford J.L., Kurie J.M., and Cohen P. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J. Biol. Chem. 275 (2000) 33607-33613
15. Schedlich L.J., O'Han M.K., Leong G.M., and Baxter R.C. Insulin-like growth factor binding protein-3 prevents retinoid receptor heterodimerization: implications for retinoic acid-sensitivity in human breast cancer cells. Biochem. Biophys. Res. Commun. 314 (2004) 83-88
16. Zappala G., Elbi C., Edwards J., Gorenstein J., Rechler M.M., and Bhattacharyya N. Induction of apoptosis in human prostate cancer cells by insulin-like growth factor binding protein-3 does not require binding to retinoid X receptor-alpha. Endocrinology 149 (2008) 1802-1812
17. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
18. Goossens G.H. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol. Behav. 94 (2008) 206-218
19. Hosogai N., Fukuhara A., Oshima K., Miyata Y., Tanaka S., Segawa K., Furukawa S., Tochino Y., Komuro R., Matsuda M., and Shimomura I. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56 (2007) 901-911
20. Ye J., Gao Z., Yin J., and He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am. J. Physiol. Endocrinol. Metab. 293 (2007) E1118-E1128
21. Trayhurn P., Wang B., and Wood I.S. Hypoxia and the endocrine and signalling role of white adipose tissue. Arch. Physiol. Biochem. 114 (2008) 267-276
22. Chen B., Lam K.S., Wang Y., Wu D., Lam M.C., Shen J., Wong L., Hoo R.L., Zhang J., and Xu A. Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem. Biophys. Res. Commun. 341 (2006) 549-556
23. Bruun J.M., Lihn A.S., Verdich C., Pedersen S.B., Toubro S., Astrup A., and Richelsen B. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E527-E533
24. Feldser D., Agani F., Iyer N.V., Pak B., Ferreira G., and Semenza G.L. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res. 59 (1999) 3915-3918
25. Grimberg A., Coleman C.M., Burns T.F., Himelstein B.P., Koch C.J., Cohen P., and El-Deiry W.S. P53-Dependent and p53-independent induction of insulin-like growth factor binding protein-3 by deoxyribonucleic acid damage and hypoxia. J. Clin. Endocrinol. Metab. 90 (2005) 3568-3574
26. Besset V., Le Magueresse-Battistoni B., Collette J., and Benahmed M. Tumor necrosis factor alpha stimulates insulin-like growth factor binding protein 3 expression in cultured porcine Sertoli cells. Endocrinology 137 (1996) 296-303
27. Rozen F., Zhang J., and Pollak M. Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breast cancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. Int. J. Oncol. 13 (1998) 865-869
28. Rajah R., Lee K.W., and Cohen P. Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: role of Bcl-2 phosphorylation. Cell Growth Differ. 13 (2002) 163-171
29. Ge K., Guermah M., Yuan C.X., Ito M., Wallberg A.E., Spiegelman B.M., and Roeder R.G. Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. Nature 417 (2002) 563-567
30. Ge K., Cho Y.W., Guo H., Hong T.B., Guermah M., Ito M., Yu H., Kalkum M., and Roeder R.G. Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor gamma-stimulated adipogenesis and target gene expression. Mol. Cell. Biol. 28 (2008) 1081-1091
31. Bhattacharyya N., Pechhold K., Shahjee H., Zappala G., Elbi C., Raaka B., Wiench M., Hong J., and Rechler M.M. Non-secreted insulin-like growth factor binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells by IGF-independent mechanisms without being concentrated in the nucleus. J. Biol. Chem. 281 (2006) 24588-24601
32. Goldberg M.A., Dunning S.P., and Bunn H.F. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 242 (1988) 1412-1415
33. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol. 64 (2002) 993-998
34. Silha J.V., Gui Y., and Murphy L.J. Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E937-E945
35. Chan S.S., Twigg S.M., Firth S.M., and Baxter R.C. Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes. J. Clin. Endocrinol. Metab. 90 (2005) 6588-6595
36. Firth S.M., and Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23 (2002) 824-854
37. Bach L.A., Headey S.J., and Norton R.S. IGF-binding proteins-the pieces are falling into place. Trends Endocrinol. Metab. 16 (2005) 228-234
38. Chan S.S., Schedlich L.J., Twigg S.M., and Baxter R.C. Inhibition of adipocyte differentiation by insulin-like growth factor binding protein-3. Am. J. Physiol. Endocrinol. Metab. 296 (2009) E654-E663